Ligand Pharmaceuticals logo

Ligand Pharmaceuticals Share Price Today

(NASDAQ: LGND)

Ligand Pharmaceuticals share price is $108.03 & ₹9,346.22 as on 20 Mar 2025, 2.30 'hrs' IST

$108.03

1.81

(1.7%)

Market is closed - opens 7 PM, 20 Mar 2025

View live Ligand Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Ligand Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ligand Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Ligand Pharmaceuticals share price movements

  • Today's Low: $105.24
    Today's High: $109.08

    Day's Volatility :3.52%

  • 52 Weeks Low: $67.72
    52 Weeks High: $129.90

    52 Weeks Volatility :47.87%

Ligand Pharmaceuticals (LGND) Returns

PeriodLigand Pharmaceuticals IncorporatedSector (Health Care)Index (Russel 2000)
3 Months
-5.19%
-9999999.0%
0.0%
6 Months
2.88%
-9999999.0%
0.0%
1 Year
47.76%
-9999999.0%
0.0%
3 Years
-4.2%
-9999999.0%
-15.2%

Ligand Pharmaceuticals (LGND) Key Statistics

in dollars & INR

Previous Close
$106.22
Open
$106.17
Today's High
$109.08
Today's Low
$105.24
Market Capitalization
$2.1B
Today's Volume
$124.8K
52 Week High
$129.9
52 Week Low
$67.72
Revenue TTM
$167.1M
EBITDA
$58.3M
Earnings Per Share (EPS)
$-0.22
Profit Margin
-2.41%
Quarterly Earnings Growth YOY
1.03%
Return On Equity TTM
-0.53%

How to invest in Ligand Pharmaceuticals Stock (LGND) from India?

It is very easy for Indian residents to invest directly in Ligand Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ligand Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ligand Pharmaceuticals or LGND on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ligand Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ligand Pharmaceuticals shares which would translate to 0.008 fractional shares of Ligand Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ligand Pharmaceuticals, in just a few clicks!

Returns in Ligand Pharmaceuticals (LGND) for Indian investors in Rupees

The Ligand Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ligand Pharmaceuticals investment value today

Current value as on today

₹1,51,831

Returns

₹51,831

(+51.83%)

Returns from Ligand Pharmaceuticals Stock

₹47,764 (+47.76%)

Dollar Returns

₹4,068 (+4.07%)

Indian investors sentiment towards Ligand Pharmaceuticals (LGND)

-56%

Period: Feb 17, 2025 to Mar 19, 2025. Change in 30 Days versus previous period

Search interest for Ligand Pharmaceuticals Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ligand Pharmaceuticals

  • BlackRock Inc

    15.30%

  • Vanguard Group Inc

    10.83%

  • HHG PLC

    5.27%

  • Macquarie Group Ltd

    4.59%

  • State Street Corp

    3.86%

  • Dimensional Fund Advisors, Inc.

    3.75%

Analyst Recommendation on Ligand Pharmaceuticals

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Ligand Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Ligand Pharmaceuticals Stock (LGND)

What analysts predicted

Upside of 33.64%

Target:

$144.38

Current:

$108.03

Insights on Ligand Pharmaceuticals Stock (Ticker Symbol: LGND)

  • Price Movement

    In the last 1 year, LGND stock has moved up by 47.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 51.81M → 42.81M (in $), with an average decrease of 17.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -7.17M → -31.08M (in $), with an average decrease of 333.5% per quarter
  • LGND vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.3% return, outperforming this stock by 23.5%
  • LGND vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 53.4% return, outperforming this stock by 56.9%
  • Price to Sales

    ForLGND every $1 of sales, investors are willing to pay $11.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Ligand Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Ligand Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Ligand Pharmaceuticals (LGND) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ligand Pharmaceuticals Incorporated logo
-9.97%
2.88%
47.76%
-4.2%
53.15%
Alnylam Pharmaceuticals, Inc. logo
1.38%
-8.28%
71.25%
56.03%
155.84%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ligand Pharmaceuticals Incorporated logo
46.27
NA
1.53
6.1
-0.01
0.02
NA
43.47
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.52
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ligand Pharmaceuticals Incorporated logo
Buy
$2.1B
53.15%
46.27
-2.41%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.6B
155.84%
NA
-12.37%

About Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; LYTENAVA to treat Opthamology; MEKINIST for cardiology; MINNEBRO for metabolic disease; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, JZP341, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; CE-furosemide for cardiology; CE-Meloxicam for neurology; V117, CX2101A, and Sitavig for infectious disease; REV-0100, OPT-302, and Reproxalap for opthamology; Vilazodone and Topiramate Injection for CNS; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
Organization
Ligand Pharmaceuticals
Employees
68
CEO
Mr. Scott M. Plesha
Industry
Health Technology

Management People of Ligand Pharmaceuticals

NameTitle
Mr. Todd C. Davis Ph.D.
Director
Mr. Octavio Espinoza
Chief Financial Officer
Mr. Andrew T. Reardon J.D.
Chief Legal Officer
Mr. Paul J. Hadden
Senior Vice President of Investments & Business Development
Dr. Keith Marschke Ph.D.
Senior Vice President of Biology & Scientific Affairs
Dr. Vincent D. Antle Ph.D.
Senior Vice President of Technical Operations & QA - Capitsol
Mr. Patrick Lucy
Senior VP & CBO Protein Expression Business
Dr. Karen R. Reeves M.D.
Senior VP of Investments & Head of Clinical Strategy
Mr. Richard B. Baxter
Senior VP of Investment Operation
Mr. Scott M. Plesha
CEO of Pelthos Therapeutics

Important FAQs about investing in LGND Stock from India :

What is Ligand Pharmaceuticals share price today?

Ligand Pharmaceuticals share price today stands at $108.03, Open: $106.17 ; Previous Close: $106.22 ; High: $109.08 ; Low: $105.24 ; 52 Week High: $129.90 ; 52 Week Low: $67.72.

The stock opens at $106.17, after a previous close of $106.22. The stock reached a daily high of $109.08 and a low of $105.24, with a 52-week high of $129.90 and a 52-week low of $67.72.

Can Indians buy Ligand Pharmaceuticals shares?

Yes, Indians can invest in the Ligand Pharmaceuticals (LGND) from India.

With INDmoney, you can buy Ligand Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ligand Pharmaceuticals at zero transaction cost.

How can I buy Ligand Pharmaceuticals shares from India?

It is very easy to buy Ligand Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ligand Pharmaceuticals (LGND) be purchased?

Yes, you can buy fractional shares of Ligand Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Ligand Pharmaceuticals stocks?

To start investing in Ligand Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ligand Pharmaceuticals Stock (LGND)?

Today’s highest price of Ligand Pharmaceuticals (LGND) is $109.08.

Today’s lowest price of Ligand Pharmaceuticals (LGND) is $105.24.

What is today's market capitalisation of Ligand Pharmaceuticals?

Today's market capitalisation of Ligand Pharmaceuticals LGND is 2.1B

What is the 52 Week High and Low Range of Ligand Pharmaceuticals Stock (LGND)?

  • 52 Week High

    $129.90

  • 52 Week Low

    $67.72

What are the historical returns of Ligand Pharmaceuticals (LGND)?

  • 1 Month Returns

    -9.97%

  • 3 Months Returns

    2.88%

  • 1 Year Returns

    47.76%

  • 5 Years Returns

    53.15%

Who is the Chief Executive Officer (CEO) of Ligand Pharmaceuticals ?

Mr. Scott M. Plesha is the current Chief Executive Officer (CEO) of Ligand Pharmaceuticals.